NO20053341D0 - Prevention and treatment of Alzheimer's disease. - Google Patents

Prevention and treatment of Alzheimer's disease.

Info

Publication number: NO20053341D0
Authority: NO; Norway
Prior art keywords: alzheimer; disease; prevention; treatment
Prior art date: 2002-12-12

Application number

NO20053341A

Other languages

Norwegian (no)

Other versions

NO20053341L (en

Inventor

Hubert Heuer

Laurent Pradier

Hans-Ludwig Schaefer

Thierry Canton

Jesus Benavides

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-12

Filing date

2005-07-08

Publication date

2005-07-08

2005-07-08 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2005-07-08 Publication of NO20053341D0 publication Critical patent/NO20053341D0/en

2005-09-07 Publication of NO20053341L publication Critical patent/NO20053341L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

NO20053341A 2002-12-12 2005-07-08 Prevention and treatment of Alzheimer's disease. NO20053341L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0215722A FR2848452B1 (en)	2002-12-12	2002-12-12	APPLICATION OF INTESTINAL BILIARY ACID RECAPTURE INHIBITORS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
PCT/FR2003/003654 WO2004062652A1 (en)	2002-12-12	2003-12-10	Prevention and treatment of alzheimer's disease

Publications (2)

Publication Number	Publication Date
NO20053341D0 true NO20053341D0 (en)	2005-07-08
NO20053341L NO20053341L (en)	2005-09-07

Family

ID=32338722

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053341A NO20053341L (en)	2002-12-12	2005-07-08	Prevention and treatment of Alzheimer's disease.

Country Status (22)

Country	Link
EP (1)	EP1572174A1 (en)
JP (1)	JP2006514063A (en)
KR (1)	KR20050084250A (en)
CN (1)	CN1726016A (en)
AR (1)	AR042354A1 (en)
AU (1)	AU2003296802A1 (en)
BR (1)	BR0317280A (en)
CA (1)	CA2507945A1 (en)
CO (1)	CO5700712A2 (en)
FR (1)	FR2848452B1 (en)
HR (1)	HRP20050534A2 (en)
MA (1)	MA27500A1 (en)
MX (1)	MXPA05005556A (en)
NO (1)	NO20053341L (en)
NZ (1)	NZ540496A (en)
PE (1)	PE20040770A1 (en)
PL (1)	PL377110A1 (en)
RS (1)	RS20050420A (en)
RU (1)	RU2005121909A (en)
TW (1)	TW200503707A (en)
WO (1)	WO2004062652A1 (en)
ZA (1)	ZA200504656B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7521481B2 (en)	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
CA2544573A1 (en)	2003-11-03	2005-06-02	Probiodrug Ag	Combinations useful for the treatment of neuronal disorders
KR101099206B1 (en)	2004-02-05	2011-12-27	프로비오드룩 아게	Novel Inhibitors of Glutaminyl Cyclase
WO2006050359A2 (en)	2004-11-02	2006-05-11	Northwestern University	Pyridazine compounds and methods
CA2650711A1 (en)	2006-04-28	2007-11-08	Northwestern University	Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
US20100298375A1 (en) *	2007-05-22	2010-11-25	Heii Arai	medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
EA030839B1 (en)	2011-10-28	2018-10-31	ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи	Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
WO2013063526A1 (en)	2011-10-28	2013-05-02	Lumena Pharmaceuticals, Inc.	Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2040996A1 (en) *	1990-05-02	1991-11-03	Robert L. Albright	Composition and method for controlling cholesterol
AU668682B2 (en) *	1991-02-22	1996-05-16	Howard K. Shapiro	Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology
EP0910351A1 (en) *	1996-06-27	1999-04-28	G.D. Searle & Co.	Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
US5985936A (en) *	1997-12-18	1999-11-16	Forbes Medi-Tech, Inc.	Method of preventing and delaying onset of Alzheimer's disease and composition therefor
CA2311356C (en) *	1998-01-28	2004-07-13	Warner-Lambert Company	Method for treating alzheimer's disease
US6080778A (en) *	1998-03-23	2000-06-27	Children's Medical Center Corporation	Methods for decreasing beta amyloid protein
DE19825804C2 (en) *	1998-06-10	2000-08-24	Aventis Pharma Gmbh	1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation and medicaments containing these compounds
US6221897B1 (en) *	1998-06-10	2001-04-24	Aventis Pharma Deutschland Gmbh	Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19845405C2 (en) *	1998-10-02	2000-07-13	Aventis Pharma Gmbh	Aryl-substituted propanolamine derivatives and their use
US20010028895A1 (en) *	2000-02-04	2001-10-11	Bisgaier Charles L.	Methods of treating alzheimer's disease
US20020028826A1 (en) *	2000-06-15	2002-03-07	Robl Jeffrey A.	HMG-CoA reductase inhibitors and method
SE0104334D0 (en) *	2001-12-19	2001-12-19	Astrazeneca Ab	Therapeutic agents
TWI329111B (en) *	2002-05-24	2010-08-21	X Ceptor Therapeutics Inc	Azepinoindole and pyridoindole derivatives as pharmaceutical agents

2002
- 2002-12-12 FR FR0215722A patent/FR2848452B1/en not_active Expired - Fee Related
2003
- 2003-12-10 KR KR1020057010595A patent/KR20050084250A/en not_active Withdrawn
- 2003-12-10 RU RU2005121909/15A patent/RU2005121909A/en not_active Application Discontinuation
- 2003-12-10 CA CA002507945A patent/CA2507945A1/en not_active Abandoned
- 2003-12-10 HR HR20050534A patent/HRP20050534A2/en not_active Application Discontinuation
- 2003-12-10 RS YUP-2005/0420A patent/RS20050420A/en unknown
- 2003-12-10 JP JP2004566119A patent/JP2006514063A/en not_active Abandoned
- 2003-12-10 AU AU2003296802A patent/AU2003296802A1/en not_active Abandoned
- 2003-12-10 PE PE2003001247A patent/PE20040770A1/en not_active Application Discontinuation
- 2003-12-10 WO PCT/FR2003/003654 patent/WO2004062652A1/en not_active Ceased
- 2003-12-10 BR BR0317280-5A patent/BR0317280A/en not_active IP Right Cessation
- 2003-12-10 EP EP03815109A patent/EP1572174A1/en not_active Withdrawn
- 2003-12-10 PL PL377110A patent/PL377110A1/en not_active Application Discontinuation
- 2003-12-10 AR ARP030104540A patent/AR042354A1/en not_active Application Discontinuation
- 2003-12-10 CN CNA2003801059727A patent/CN1726016A/en active Pending
- 2003-12-10 NZ NZ540496A patent/NZ540496A/en unknown
- 2003-12-10 MX MXPA05005556A patent/MXPA05005556A/en not_active Application Discontinuation
- 2003-12-11 TW TW092134949A patent/TW200503707A/en unknown
2005
- 2005-06-07 ZA ZA200504656A patent/ZA200504656B/en unknown
- 2005-06-09 CO CO05056010A patent/CO5700712A2/en not_active Application Discontinuation
- 2005-06-10 MA MA28329A patent/MA27500A1/en unknown
- 2005-07-08 NO NO20053341A patent/NO20053341L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2507945A1 (en)	2004-07-29
NZ540496A (en)	2008-04-30
NO20053341L (en)	2005-09-07
FR2848452B1 (en)	2007-04-06
PE20040770A1 (en)	2004-12-10
MXPA05005556A (en)	2005-07-26
FR2848452A1 (en)	2004-06-18
MA27500A1 (en)	2005-08-01
TW200503707A (en)	2005-02-01
HRP20050534A2 (en)	2006-11-30
RS20050420A (en)	2007-04-10
RU2005121909A (en)	2006-01-20
AU2003296802A1 (en)	2004-08-10
EP1572174A1 (en)	2005-09-14
AR042354A1 (en)	2005-06-15
ZA200504656B (en)	2006-08-30
BR0317280A (en)	2005-11-08
WO2004062652A1 (en)	2004-07-29
JP2006514063A (en)	2006-04-27
CO5700712A2 (en)	2006-11-30
KR20050084250A (en)	2005-08-26
PL377110A1 (en)	2006-01-23
CN1726016A (en)	2006-01-25

Publication	Publication Date	Title
DK1303272T3 (en)	2008-05-26	Benzothiazole derivatives for the treatment of Alzheimer's disease and Parkinson's disease
NO20022531D0 (en)	2002-05-28	Vaccine for the prevention and treatment of Alzheimer's and amyloid-related diseases
NO20041452L (en)	2004-06-04	17-beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen-dependent diseases.
DK1392287T3 (en)	2007-03-19	Use of substituted azetidinone derivatives in the treatment of Alzheimer's disease
NO20015773D0 (en)	2001-11-27	Prevention and treatment of amyloidogenic disease
GB0223040D0 (en)	2002-11-13	Therapeutic compounds
DK1765388T3 (en)	2013-07-22	COMBINATION THERAPY FOR PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE, AND KIT THEREOF
IL245955B (en)	2018-01-31	Immunogenic preparations for the prevention and treatment of inflammatory bowel disease
CY2014028I1 (en)	2015-12-09	COMPOUNDS, PHARMACEUTICAL FORMS AND METHODS FOR THE TREATMENT OR PREVENTION OF ACNE ROSEPHUM
DE60330335D1 (en)	2010-01-14	ENDOSCOPIC INFORMATION PROCESSOR AND PROCESSING METHOD
AU2003220096A8 (en)	2003-09-22	Methods for alzheimer's disease treatment and cognitive enhancement
AU2003226014A8 (en)	2003-10-13	Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
GB0117645D0 (en)	2001-09-12	Therapeutic stratergies for prevention and treatment of alzheimers disease
DK2527315T3 (en)	2014-06-02	Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
EP1578253A4 (en)	2008-11-12	PREVENTION AND TREATMENT OF SYNUCLEOPATHIC DISEASE
NO20053855D0 (en)	2005-08-18	1-Phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases.
AU2003206413A8 (en)	2003-07-24	Substituted amino carboxamides for the treatment of alzheimer's disease
IS8135A (en)	2005-11-21	Tricyclic indole derivatives and their use in the treatment of Alzheimer's disease
DK2380583T3 (en)	2013-12-02	Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
AU2003231252A1 (en)	2003-11-11	Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease
IS8004A (en)	2005-08-29	Method for the treatment of mild cognitive impairment and for the prevention or delay of Alzheimer's disease
NO20053341D0 (en)	2005-07-08	Prevention and treatment of Alzheimer's disease.
NO20040659L (en)	2004-02-13	Isoxazolopyridinones and their use in the treatment of Parkinson's disease
AU2003303141A8 (en)	2004-07-22	Hydroxypropyl amides for the treatment of alzheimer's disease
NO20033228L (en)	2003-09-26	Use of IL-18 inhibitors for the treatment and / or prevention of heart disease

Legal Events

Date	Code	Title	Description
2009-07-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application